Gosset Ownership
Private
Therapeutic Areas
Stage
Commercial
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Modalities
BioProduction Systems General Information
BioProduction Systems is an active CDMO specializing in the development and scalable manufacturing of recombinant proteins using mammalian (CHO), microbial (E. coli), and other cell systems. They offer process development from early-stage to commercial scale with expertise in analytics, lyophilization, fill-finish drug product work, advanced cell banking, cultivated meat production technologies, probiotics manufacture, and real-time data access for clients. No clinical trial results are reported as they are a service provider.
Contact Information
Primary Industry
Contract Manufacturing Organization
Corporate Office
,
United States
United States
Drug Pipeline
No pipeline data available
Key Partnerships
Not publicly listed; likely works with various biotech/pharma clients under confidentiality agreements
BioProduction Systems Funding
No funding data available
To view BioProduction Systems's complete valuation and funding history, request access »